Vincent P. Ippolito is EVP & Sales & Marketing at MEDICIS PHARMACEUTICAL CORP (MRX). They have made 8 open-market trades across 2 companies since 2010, most recently 2016-06-24.
CIK 0001411158
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAC | SELL | 2016-03-02 | 2016-03-04 | $63.86 | $575K | +0.3% | +2.5% | +65.5% |
| ANAC | SELL | 2016-03-02 | 2016-03-04 | $64.08 | $931K | +0.3% | +2.5% | +65.5% |
| ANAC | SELL | 2016-01-19 | 2016-01-21 | $95.41 | $1.9M | -23.3% | -21.1% | -36.2% |
| ANAC | SELL | 2016-01-19 | 2016-01-21 | $95.40 | $1.9M | -23.3% | -21.1% | -36.2% |
| ANAC | SELL | 2016-01-04 | 2016-01-05 | $112.21 | $62K | -16.7% | -30.2% | -45.4% |
| ANAC | SELL | 2016-01-04 | 2016-01-05 | $112.38 | $181K | -16.7% | -30.2% | -45.4% |
| ANAC | SELL · 10b5-1 | 2015-12-09 | 2015-12-11 | $107.90 | $2.2M | -19.4% | -19.7% | -46.3% |
| ANAC | SELL · 10b5-1 | 2015-03-03 | 2015-03-04 | $43.88 | $395K | -19.4% | +2.3% | +2.3% |
| MRX | SELL | 2011-05-13 | 2011-05-17 | $36.88 | $4.2M | +2.8% | +2.3% | +2.3% |
| MRX | SELL | 2010-08-12 | 2010-08-16 | $26.90 | $350K | +2.8% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.